Cargando…
Improvement of Antialveolar echinococcosis efficacy of novel Albendazole-Bile acids Derivatives with Enhanced Oral Bioavailability
Alveolar echinococcosis (AE) is a chronic and fatal infectious parasitic disease, which has not been well-researched. Current recommended therapies for AE by the World Health Organization include complete removal of the infected tissue followed by two years of albendazole (ABZ), administered orally,...
Autores principales: | Hu, Chunhui, Qin, Meng, Zhang, Fabin, Gao, Ruixue, Gan, Xuehui, Du, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838834/ https://www.ncbi.nlm.nih.gov/pubmed/36595544 http://dx.doi.org/10.1371/journal.pntd.0011031 |
Ejemplares similares
-
Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice
por: Gómez, Cristina, et al.
Publicado: (2021) -
The Investigation of the Effect and Mechanism of Sophora moorcroftiana Alkaloids in Combination with Albendazole on Echinococcosis in an Experimental Rats Model
por: Zhang, Fabin, et al.
Publicado: (2018) -
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice
por: Abulaihaiti, Maitiseyiti, et al.
Publicado: (2015) -
Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014) -
Echinococcosis and Albendazole: A Case for Suitable Treatment
por: Horton, John
Publicado: (2018)